Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Merck & Co (NY: MRK)
66.16 USD  +0.14 (+0.21%)
Official Closing Price  /  Updated: 8:04 PM EDT, Jun 23, 2017  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 14,093,453
Open 66.04
Bid (Size) 66.08 (100)
Ask (Size) 66.15 (500)
Prev. Close 66.02
Today's Range 65.84 - 66.39
52wk Range 55.10 - 66.80
Shares Outstanding 2,735,164,510
Dividend Yield 2.83%
Performance
YTD
+9.99%
+9.99%
1 Month
+1.72%
+1.72%
3 Month
+4.70%
+4.70%
6 Month
+10.65%
+10.65%
1 Year
+18.40%
+18.40%
Top News
More News
Apple, JPMorgan Among 5 Dow Stocks Building Bases; S&P 500 Futures Up
Stock futures were little changed Thursday night. But investors should keep an eye on Apple, JPMorgan Chase, Home Depot, American Express and Merck. Read More
category Stock Market Today
from Investor's Business Daily
Indexes Up Mildly, But Health Stocks In Focus; Tesla Scores New High
Indexes rose slightly in afternoon trading Thursday as Wall Street digested strong earnings from Oracle and a new version of the GOP ObamaCare repeal bill. Read More
category Stock Market Today
from Investor's Business Daily
More News
Read More
UnitedHealth, HCA, Merck Rally As Senate TrumpCare Bill Pares Near-Term Cuts
category News
from Investor's Business Daily
How Dow's Merck Is Still Beating Bristol, Roche In Immuno-Oncology
category Technology
from Investor's Business Daily
Merck and Premier Inc. Expand Collaboration to Address Chronic Care and Vaccination Rates
from Business Wire News Releases
Stocks End Lower As Oil Takes Toll; Drugmakers A Bright Spot
category Stock Market Today
from Investor's Business Daily
CORRECTED-Germany's Merck gets EU backing for oral MS drug
category companyNews
from Reuters: Company News
Could Tesaro Overcome Clovis' Lead On Combos With Merck & Co.?
category Technology
from Investor's Business Daily
The FDA Has Never Approved a Drug Like This in Its 111-Year History
category MRK
from Motley Fool
NVS Scores with Positive Data, Shire ADHD Drug Gets FDA Nod
category Stocks / Equities , Pharma/Biotech , Healthcare
from Blogs - TalkMarkets
BRIEF-Leap Therapeutics says Merck will sponsor and fund initial trials of their combo drug study
category companyNews
from Reuters: Company News
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial